{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.11.1058",
  "meta" : {
    "versionId" : "24",
    "lastUpdated" : "2017-08-26T01:00:05.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "NCQA PHEMUR Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2022-12-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2017-08-26"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1058",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.11.1058"
    }
  ],
  "version" : "20170826",
  "name" : "Mephobarbital",
  "title" : "Mephobarbital",
  "status" : "active",
  "experimental" : false,
  "date" : "2017-08-26T01:00:05-04:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: Under Development),(Data Element Scope: Under Development),(Inclusion Criteria: Under Development),(Exclusion Criteria: Under Development)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "199340",
            "display" : "Mephobarbital 60 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:95cf8921-1cb7-47f0-ad8c-e6db287eff62",
    "timestamp" : "2023-11-26T21:02:40-05:00",
    "total" : 0
  }
}
